enCore Energy Corp. Logo

enCore Energy Corp.

American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.

EU | NDAQ

Overview

Corporate Details

ISIN(s):
CA29259W7008 (+1 more)
LEI:
Country:
United States of America
Address:
101 N. SHORELINE BLVD, SUITE 450, 78401 CORPUS CHRISTI
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

enCore Energy Corp. is an American uranium production company focused on providing fuel for the U.S. nuclear energy sector. The company specializes in and solely utilizes In-Situ Recovery (ISR), a proven, lower-cost, and environmentally friendly uranium extraction technology. enCore is a key domestic supplier, distinguished by operating multiple Central Processing Plants, including its Rosita and Alta Mesa facilities in South Texas, which commenced production in 2023 and 2024. The company maintains a robust growth pipeline with advanced-stage development projects, including the Dewey Burdock project in South Dakota and the Gas Hills project in Wyoming, to support the long-term demand for clean nuclear energy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all enCore Energy Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for enCore Energy Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for enCore Energy Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX
IMMUTEP Ltd Logo
Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.
United States of America IMMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.